[go: up one dir, main page]

DK1835021T3 - Ny stamme tildelt anti-sygdomsegenskaber mod værts- og bakteriel cellesammensætning - Google Patents

Ny stamme tildelt anti-sygdomsegenskaber mod værts- og bakteriel cellesammensætning

Info

Publication number
DK1835021T3
DK1835021T3 DK05851002.5T DK05851002T DK1835021T3 DK 1835021 T3 DK1835021 T3 DK 1835021T3 DK 05851002 T DK05851002 T DK 05851002T DK 1835021 T3 DK1835021 T3 DK 1835021T3
Authority
DK
Denmark
Prior art keywords
bacterial cell
cell composition
properties against
new strain
against host
Prior art date
Application number
DK05851002.5T
Other languages
English (en)
Inventor
Takehiro Miwa
Hiroshi Watanabe
Mamoru Ishihara
Tsuneo Hino
Narito Asanuma
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of DK1835021T3 publication Critical patent/DK1835021T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK05851002.5T 2004-12-28 2005-12-28 Ny stamme tildelt anti-sygdomsegenskaber mod værts- og bakteriel cellesammensætning DK1835021T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004379693 2004-12-28
PCT/JP2005/024144 WO2006070891A1 (ja) 2004-12-28 2005-12-28 宿主に対して抗病性を付与する新規な菌株および菌体組成物

Publications (1)

Publication Number Publication Date
DK1835021T3 true DK1835021T3 (da) 2011-04-18

Family

ID=36615002

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05851002.5T DK1835021T3 (da) 2004-12-28 2005-12-28 Ny stamme tildelt anti-sygdomsegenskaber mod værts- og bakteriel cellesammensætning

Country Status (12)

Country Link
US (1) US8728794B2 (da)
EP (1) EP1835021B1 (da)
JP (1) JP4953824B2 (da)
KR (1) KR101102914B1 (da)
CN (1) CN101124318B (da)
AT (1) ATE498679T1 (da)
BR (1) BRPI0519426A2 (da)
DE (1) DE602005026452D1 (da)
DK (1) DK1835021T3 (da)
ES (1) ES2358746T3 (da)
PT (1) PT1835021E (da)
WO (1) WO2006070891A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110059168A1 (en) * 2009-09-09 2011-03-10 Ang Sam Method for correcting intestinal glutamine synthetase deficiency
KR101371554B1 (ko) 2011-12-21 2014-03-10 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
CN110201003A (zh) 2012-02-29 2019-09-06 伊西康内外科公司 微生物区系的组合物及与其相关的方法
KR101364749B1 (ko) 2013-12-03 2014-02-27 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
KR101364748B1 (ko) 2013-12-03 2014-02-27 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
KR101364747B1 (ko) * 2013-12-03 2014-02-27 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
CN113730442A (zh) 2014-10-31 2021-12-03 潘德勒姆治疗公司 与病症的微生物治疗和诊断有关的方法和组合物
US11452746B2 (en) 2015-01-09 2022-09-27 Wageningen Universiteit Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
AU2019306649A1 (en) 2018-07-19 2021-02-04 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914346A (en) * 1996-11-05 1999-06-22 Wisconsin Alumni Research Foundation Methods of treating animals to enhance natural killer lymphocyte function
JP2003073269A (ja) * 1998-03-17 2003-03-12 Conlinco Inc 共役リノール酸組成物
US6696584B2 (en) * 1998-05-04 2004-02-24 Natural Asa Isomer enriched conjugated linoleic acid compositions
JPWO2002080947A1 (ja) * 2001-04-06 2004-07-29 株式会社京都動物検査センター 酪酸転化能を有する菌含有組成物及びそれを用いた消化管の乳酸過多及び大腸がんの予防・治療方法
US6677470B2 (en) * 2001-11-20 2004-01-13 Natural Asa Functional acylglycerides
JP4108613B2 (ja) * 2002-04-12 2008-06-25 チェビジェン・インコーポレイテッド 共役リノール酸を生産する新規の菌主、これを含有するカプセル剤及びその製造方法
ES2204328B1 (es) * 2002-10-04 2005-09-01 Consejo Sup. De Invest. Cientificas Procedimiento de produccion de acidos grasos polinsaturados con levaduras por incorporacion de sustratos olefinicos o acetilenicos.
CN1248697C (zh) * 2003-11-13 2006-04-05 荀涣仁 一种治疗慢性肠炎的药物组合物及其制备方法

Also Published As

Publication number Publication date
WO2006070891A1 (ja) 2006-07-06
EP1835021B1 (en) 2011-02-16
JP4953824B2 (ja) 2012-06-13
CN101124318A (zh) 2008-02-13
BRPI0519426A2 (pt) 2009-01-20
ATE498679T1 (de) 2011-03-15
ES2358746T3 (es) 2011-05-13
KR20070091212A (ko) 2007-09-07
CN101124318B (zh) 2013-01-09
JPWO2006070891A1 (ja) 2008-06-12
US20080095745A1 (en) 2008-04-24
PT1835021E (pt) 2011-04-29
DE602005026452D1 (de) 2011-03-31
US8728794B2 (en) 2014-05-20
EP1835021A4 (en) 2008-11-05
EP1835021A1 (en) 2007-09-19
KR101102914B1 (ko) 2012-01-10

Similar Documents

Publication Publication Date Title
NO20076059L (no) 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer
BRPI0506713A (pt) composições de ácido peroxicarboxìlico de cadeia média
BRPI0715243A2 (pt) "método de aumento da produção de etanol e linhagem de z. mobilis"
DE602006015665D1 (de) Probiotische enterokokken für eine verbesserte immunität
EA200802054A1 (ru) Ингибиторы фермента
WO2008042231A3 (en) Compositions and methods for evaluating and treating heart failure
PL2426220T3 (pl) Wyznakowane mikroorganizmy i sposoby wyznakowania
BRPI0810719A8 (pt) Inibidores da enzima diacilglicerol o-acetiltansferase tipo 1
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2007022529A3 (en) Method of treating inflammatory diseases
EP1863507A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACNE
NO20071127L (no) Triazoloftalaziner
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
TW200611699A (en) Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
PL1841743T3 (pl) Amidy kwasu 3-arylo-3-hydroksy-2-aminopropionowego, amidy kwasu 3-heteroarylo-3-hydroksy-2-aminopropionowego i powiązane związki o działaniu przeciwbólowym i/lub immunostymulacyjnym
DK1835021T3 (da) Ny stamme tildelt anti-sygdomsegenskaber mod værts- og bakteriel cellesammensætning
DK2561880T3 (da) Mælkesyrebakterier som priobiotiske stammer og sammensætninger dermed
EP1771558A4 (en) INHIBITION OF BIOFILMATION
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
NO20083157L (no) Organofil leire og framgangsmate for framstilling og anvendelse av samme
NO20073652L (no) Enantiomerer av 3-heteroaryl-8H-8-azabisyklo(3.2.1)okt-2-en og deres anvendelse som monoaminnevrotransmitter-gjenopptaksinhibitorer
FR2881751B1 (fr) Compositions comprenant des micro-organismes deshydrates, leurs procedes de preparation, et leurs utilisations
NO20073276L (no) Metode for fremstilling av aminoetoksybenzylalkoholer
WO2006033691A3 (en) Copy choice recombination and uses thereof
EP1877539A4 (en) Mutant f. tularensis strain and uses thereof